Intraocular dynamics of vascular endothelial growth factor levels in patients with neovascular glaucoma
Not Applicable
- Conditions
- neovascular glaucoma
- Registration Number
- JPRN-UMIN000003646
- Lead Sponsor
- Osaka University Hospital, Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Eyes with a past history of intravitreal pharmacotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of aqueous humor VEGF concentrations and intraocular pressures beore and after the high- and low-doses of intravitreal bevacizumab
- Secondary Outcome Measures
Name Time Method Clinical evaluation of the changes in iris and angle neovascularization before and after the high- and low-doses of intravitreal bevacizumab